{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-08-15T12:22:38.341188+00:00",
  "news": [
    {
      "title": "US judge overturns Amgen's $50.3 mln loss in cancer drug patent case - Reuters",
      "link": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitgFBVV95cUxPMmtjZnZnZXdyRGJKWnpCbDJOWXJMdnhqTlJORXNBTkNFRHpqWk1UYVdleE9OUGpEVWhheUtmUHloVk55OUZ4eVVJUVR1UFhtS2NRT1Z5QnNSTHNLamNuOE9lVHczVnc0a3pjVE5aaThPSmdCb25vMVFFT0ZKWF9iMEtzLTI0cjc0dEVHU1hXMHZZdENWUmpLY2JRM243NXBKWmRlN25lZUYyZGUzX3BjWEkxam8wQQ?oc=5\" target=\"_blank\">US judge overturns Amgen's $50.3 mln loss in cancer drug patent case</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-14T19:28:47+00:00",
      "source": "Reuters"
    },
    {
      "title": "Boston Partners Decreases Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNTnZTMmE3RUM3b3dXVVdKazJma1lmNkI5RjRmb3VseWZ4d19rcEthUGRBc1ZVN1hrU1NKOVJUUUp4aHhtZ0YtZTBqd3Vnb2xNRHY2d2JpZWh1d0J1LTR1N2RLdE82UE14VFpSOWdNV0dDMU1BQ2ZndVZ0b0lqVk4tcU90MkctblhIejRmWjlnQUhNR1VnVzRPYzNLcE5zT3pWNHJaV2x1WHFuSkdaZDZWbzVsV3JUOTlHS1FN?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNTnZTMmE3RUM3b3dXVVdKazJma1lmNkI5RjRmb3VseWZ4d19rcEthUGRBc1ZVN1hrU1NKOVJUUUp4aHhtZ0YtZTBqd3Vnb2xNRHY2d2JpZWh1d0J1LTR1N2RLdE82UE14VFpSOWdNV0dDMU1BQ2ZndVZ0b0lqVk4tcU90MkctblhIejRmWjlnQUhNR1VnVzRPYzNLcE5zT3pWNHJaV2x1WHFuSkdaZDZWbzVsV3JUOTlHS1FN?oc=5\" target=\"_blank\">Boston Partners Decreases Position in Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-15T11:25:07+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Judge Says Patents In $50M Amgen Jury Loss Unenforceable - Law360",
      "link": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQV19ZMFR6MFNPeXhyc3RRVnRnZFE1dTFZOGxQWkNEMkRqT2RpT2M0WmFrUjd1ZDZYeFdYdlc5eEtvYUY0eG5UTjJWdmFJcU96RGc5bUhkZ3pkSHc0TUd6cVVyUWx6NHM2bWozWXZGM19fRlZBbUlrNUU2YVRGS1l0QVJfWDRMR2JseGRsS0tyZGMzZUx5aF9IMjJTcVTSAVZBVV95cUxNV0Q0bkJ6cTVpR0pPYWJpc0hVUmNwTnhuVzV3NUNjTS1SM01OYUtjMHFwa0l1dWpLOW9wQmVOZXV5WG1IVnZ6dWVGV2Jkc0llcTMtRENDZw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinAFBVV95cUxQV19ZMFR6MFNPeXhyc3RRVnRnZFE1dTFZOGxQWkNEMkRqT2RpT2M0WmFrUjd1ZDZYeFdYdlc5eEtvYUY0eG5UTjJWdmFJcU96RGc5bUhkZ3pkSHc0TUd6cVVyUWx6NHM2bWozWXZGM19fRlZBbUlrNUU2YVRGS1l0QVJfWDRMR2JseGRsS0tyZGMzZUx5aF9IMjJTcVTSAVZBVV95cUxNV0Q0bkJ6cTVpR0pPYWJpc0hVUmNwTnhuVzV3NUNjTS1SM01OYUtjMHFwa0l1dWpLOW9wQmVOZXV5WG1IVnZ6dWVGV2Jkc0llcTMtRENDZw?oc=5\" target=\"_blank\">Judge Says Patents In $50M Amgen Jury Loss Unenforceable</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Law360</font>",
      "published": "2025-08-15T01:32:00+00:00",
      "source": "Law360"
    },
    {
      "title": "Back To Basics: Why I Favor Amgen Over Johnson & Johnson (NYSE:JNJ) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMinwFBVV95cUxNZEplYW4tU25LeHZ5WjAxdEV0SDVlWldYQzZNci1ZenNVSkNGSDlDcjZ5SzJJSHVnZzFSRDFkeTBqZmQwa19kWW40ZHBMTUhELXBKakpaTVM1bHl5dWtxemlJNTVOSjFzZGZRYnJidXRiR0dnTVNZMEx0STFjZlZnRWNEWFV2djJULWlEeE03X19tbmpuMW01MjdfVGF2RDQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMinwFBVV95cUxNZEplYW4tU25LeHZ5WjAxdEV0SDVlWldYQzZNci1ZenNVSkNGSDlDcjZ5SzJJSHVnZzFSRDFkeTBqZmQwa19kWW40ZHBMTUhELXBKakpaTVM1bHl5dWtxemlJNTVOSjFzZGZRYnJidXRiR0dnTVNZMEx0STFjZlZnRWNEWFV2djJULWlEeE03X19tbmpuMW01MjdfVGF2RDQ?oc=5\" target=\"_blank\">Back To Basics: Why I Favor Amgen Over Johnson & Johnson (NYSE:JNJ)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-08-14T19:06:55+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Analyst recommendations: Amgen, Applied Materials, Cisco, Nvidia, Oracle… - MarketScreener",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQVnpJMXh4RGFUWVk1WHd4VTQ3UWJzVzRVc0JzQUNvbEc3R3VNWXNOMXJqNDNDcVZwT1p6RXRvRWFyTTRrWG9LYi1kcU1FR3k2Z2RyYmt5QVJKUmxfSVI3TlFYdmpqNm9nTEtVMkl5ckpvMERUZ21oTDh1SlJmUHJZclNvdWZmaF80WmVWXy1JSVhZeDJiNm14TXhhUXp0cVlQNGJ4OURpOHFPY3hDeEhOckVDX0ZJSGVWTi00ay1nSQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQVnpJMXh4RGFUWVk1WHd4VTQ3UWJzVzRVc0JzQUNvbEc3R3VNWXNOMXJqNDNDcVZwT1p6RXRvRWFyTTRrWG9LYi1kcU1FR3k2Z2RyYmt5QVJKUmxfSVI3TlFYdmpqNm9nTEtVMkl5ckpvMERUZ21oTDh1SlJmUHJZclNvdWZmaF80WmVWXy1JSVhZeDJiNm14TXhhUXp0cVlQNGJ4OURpOHFPY3hDeEhOckVDX0ZJSGVWTi00ay1nSQ?oc=5\" target=\"_blank\">Analyst recommendations: Amgen, Applied Materials, Cisco, Nvidia, Oracle…</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketScreener</font>",
      "published": "2025-08-15T09:36:26+00:00",
      "source": "MarketScreener"
    },
    {
      "title": "Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOQ3R0OFR1T18zOVFlMC1YTl8tZ2s5S2c5WVdHT25DRFhZQnF1VzQwVGd5Z2hJS3FWUExTSGc0dWoyc2ZWSVo1eF9GNG9DVFZlNjdPLWt3SUIxQjktMXRRcURtR25xSG5VbXY1QXJsOGhaUGpUZmp1VHcwUWFYRE5uclZzMFVrOUpMdTJ3SGU1Y0pNdWFLc2dB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOQ3R0OFR1T18zOVFlMC1YTl8tZ2s5S2c5WVdHT25DRFhZQnF1VzQwVGd5Z2hJS3FWUExTSGc0dWoyc2ZWSVo1eF9GNG9DVFZlNjdPLWt3SUIxQjktMXRRcURtR25xSG5VbXY1QXJsOGhaUGpUZmp1VHcwUWFYRE5uclZzMFVrOUpMdTJ3SGU1Y0pNdWFLc2dB?oc=5\" target=\"_blank\">Amgen Announces Bemarituzumab’s Successful Phase 3 Results in FGFR2b+ Gastric Cancer</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-12T00:24:18+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen’s Promising Cardiovascular Study: A Potential Game Changer? - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPandZSlJVaXVVQmtPelVRYUsxQmxGeVdzNVNCYTRpcHNXY3RneGljRGpEU1ZBOHk4Sl9yblFfb0JZSF9wcGh4UFoxYVZzUDF4NjN0UnZveWY3bjBrdkVMTk5ibEpxaTdKRHY4QlBMVENZZVg2UUZqdFdrbGJqYk5lWXdmclVudm9VS0hIZXFvQjhXWDY2RVVXLV8wbVlVSC1oUVdkTTdaZGRpSnRJUHRUWkJiTzU0TFk?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMitwFBVV95cUxPandZSlJVaXVVQmtPelVRYUsxQmxGeVdzNVNCYTRpcHNXY3RneGljRGpEU1ZBOHk4Sl9yblFfb0JZSF9wcGh4UFoxYVZzUDF4NjN0UnZveWY3bjBrdkVMTk5ibEpxaTdKRHY4QlBMVENZZVg2UUZqdFdrbGJqYk5lWXdmclVudm9VS0hIZXFvQjhXWDY2RVVXLV8wbVlVSC1oUVdkTTdaZGRpSnRJUHRUWkJiTzU0TFk?oc=5\" target=\"_blank\">Amgen’s Promising Cardiovascular Study: A Potential Game Changer?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-08-14T16:24:06+00:00",
      "source": "TipRanks"
    },
    {
      "title": "Neuberger Berman Group LLC Sells 12,327 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOb2ZCTXVwUkZDQWZYNEMzMlJQSkpvbVNVQ1dTdldzQnJMRUtCLWVsbUlCYWFIeVFqX2JXR1N2WDhvejBnSkRqZjZJMy1QVEFWX0lUd0lKUW1naklkdXJjRF92OTFudzZ5TFRzNmtESmRUejVyZGNmUXFfZkdLU3RYU1UzXzdzU1ZKY0ZwNmQydXR6SXh2QVV2dzNBcXk2VXNpRl9yYUxJX0c1cXVLREtaeXVzdng1ZU91emsyS1ZRQ1VBRlhybVhYVHJ3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxOb2ZCTXVwUkZDQWZYNEMzMlJQSkpvbVNVQ1dTdldzQnJMRUtCLWVsbUlCYWFIeVFqX2JXR1N2WDhvejBnSkRqZjZJMy1QVEFWX0lUd0lKUW1naklkdXJjRF92OTFudzZ5TFRzNmtESmRUejVyZGNmUXFfZkdLU3RYU1UzXzdzU1ZKY0ZwNmQydXR6SXh2QVV2dzNBcXk2VXNpRl9yYUxJX0c1cXVLREtaeXVzdng1ZU91emsyS1ZRQ1VBRlhybVhYVHJ3?oc=5\" target=\"_blank\">Neuberger Berman Group LLC Sells 12,327 Shares of Amgen Inc. (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-08-15T11:25:07+00:00",
      "source": "MarketBeat"
    }
  ],
  "product_launches": [
    {
      "title": "Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva - koreabiomed.com",
      "link": "https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMibkFVX3lxTE51eEtJYkhkRHFlaDJiREhrQ3FTNFpINXVRT2xkNUo1dFROdWJLUF9fcm9EWVNWeW44S2JmR2FwQWpERUxRODRaTkZWRmpmQmFjWkQ5b0NaVm5DY005ZGlhTzQ4T2Z3ejJkT202am1R0gFyQVVfeXFMTWR6QWpUU2tQdnNiYmF2clROVVFIU2NFQzdnV3JOZUF0cHVaYVVmYTk0a01CSjA5N3ZMcnpZSllXWHhtWXZocnJySlgtMjhrbS1Yd1pIdEdOSzVVczllV0tFRHZRRjJ0dnJvbjZKOEdGandn?oc=5\" target=\"_blank\">Boryung launches Samsung Bioepis' bone cancer biosimilar with storage edge over Amgen's Xgeva</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">koreabiomed.com</font>",
      "published": "2025-08-04T01:50:03+00:00",
      "source": "koreabiomed.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US - FirstWord Pharma",
      "link": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5VckVQdjB2RUpTc0p0YU1DYnpKMGJHbUt0b3djeEI1Sk91Mm9NLWJPQmpLUEhNYUtBZ1BUa21RVlQxcEhHdXpMa3dNMUs4NTd5dDhn?oc=5\" target=\"_blank\">Sandoz files antitrust suit in latest bid to launch biosimilar of Amgen's Enbrel in US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font>",
      "published": "2025-04-14T07:00:00+00:00",
      "source": "FirstWord Pharma"
    },
    {
      "title": "Strong first-quarter product sales for Amgen - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxObE5kVHJ3TmlvdEhBTmplQjgtVEVfdE1LQ1hmcmw2UThFaTg4aVk4eEtMbjdPR0dabHBaM0dMczZ5MlB2QWlxaDBCcXh3ZkRDWFVpbVRDMjQxbXdNS2JrYzFQYWd5ZWw3S0ZEcGdGRTRKRFE3eWszOFFkX1A0QWpfdkxB?oc=5\" target=\"_blank\">Strong first-quarter product sales for Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-05-02T07:00:00+00:00",
      "source": "The Pharma Letter"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-08-14",
      "close": 290.2900085449219
    },
    "history": [
      {
        "date": "2025-08-06",
        "close": 284.6700134277344
      },
      {
        "date": "2025-08-07",
        "close": 284.70001220703125
      },
      {
        "date": "2025-08-08",
        "close": 288.2300109863281
      },
      {
        "date": "2025-08-11",
        "close": 285.0899963378906
      },
      {
        "date": "2025-08-12",
        "close": 284.9800109863281
      },
      {
        "date": "2025-08-13",
        "close": 289.3299865722656
      },
      {
        "date": "2025-08-14",
        "close": 290.2900085449219
      }
    ],
    "name": "Amgen Inc."
  }
}